Omnigen‘s innovative Discover Me platform integrates health and genetic data on a large and diverse set of people. The company works with leading pharmaceutical partners to discover novel targets for new medicines and diagnostic tools. It can identify people that are more likely to benefit from treatments, design better clinical trials and refer participants to them, including for rare diseases.
Shackleton provided growth finance to Omnigen in 2023.